vimarsana.com

Brokerages expect Vaxxinity, Inc. (NASDAQ:VAXX – Get Rating) to report earnings of ($0.38) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Vaxxinity’s earnings, with estimates ranging from ($0.40) to ($0.35). The firm is expected to issue its next earnings results on Monday, January 1st. On average, […]

Related Keywords

United States , ,Geode Capital Management ,Securities Exchange Commission ,Goldman Sachs Group Inc ,Zacks Investment Research ,Investment Advisers ,United Biomedical Inc ,Vaxxinity Company Profile Get Rating ,Managers Group ,Nasdaq ,Vaxxinity Inc ,Get Rating ,Investment Research ,Exchange Commission ,Capital Management ,Sachs Group ,Adage Capital Partners ,Company Profile ,Lewy Body ,Vaxxinity ,Nasdaq Vaxx ,Vaxx ,Medical ,Ratings ,Consensus ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.